Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
Conditions
Focal Segmental Glomerulosclerosis · Minimal Change Disease · Immunoglobulin A Nephropathy · IgA Vasculitis · Alport Syndrome
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Cedars-Sinai Medical Center, Los Angeles, California, United States
Nemours Children's Hospital, Wilmington, Delaware, United States
University of Miami, Leonard M. Miller School of Medicine, Miami, Florida, United States
Nicklaus Children's Hospital, Miami, Florida, United States
University of Iowa, Stead Family Children's Hospital, Iowa City, Iowa, United States
Floating Hospital for Children at Tufts Medical Center, Boston, Massachusetts, United States
C.S. Mott Children's Hospital, Ann Arbor, Michigan, United States
University of Minnesota, Masonic Children's Hospital, Minneapolis, Minnesota, United States
Children's Mercy Hospitals and Clinics, Kansas City, Missouri, United States
Hackensack University Medical Center, Hackensack, New Jersey, United States
Jersey Shore University Medical Center, Neptune City, New Jersey, United States
Cohen Children's Medical Center, New Hyde Park, New York, United States
Fink Children's Ambulatory Care Center, New York, New York, United States
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States
Atrium Health Levine Children's Hospital, Charlotte, North Carolina, United States
Duke Molecular Physiology Institute, Durham, North Carolina, United States
Nationwide Children's Hospital, Columbus, Ohio, United States
University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City, Oklahoma, United States
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
St. Christopher's Hospital for Children, Philadelphia, Pennsylvania, United States
Texas Children's Hospital, Houston, Texas, United States
UT Health - John P. and Kathrine G. McGovern Medical School, Houston, Texas, United States
Seattle Children's Hospital, Seattle, Washington, United States
Uniklinik Köln, Klinik und Poliklinik für Kinder- und Jugendmedizin, Cologne, Germany
Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Universitätsklinikum Heidelberg - Angelika Lautenschläger - Kinderklinik, Heidelberg, Germany
Policlinico Bari Ospedale Pediatrico Giovanni XXIII, Bari, Italy
IRCCS Istituto Giannina Gaslini, Genova, Italy
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
Azienda Ospedale Università di Padova, Padova, Italy
Ospedale Pediatrico Bambino Gesù, Roma, Italy
Emma Kinderziekenhuis, Amsterdam, Netherlands
Radboud Universitair Medisch Centrum, Nijmegen, Netherlands
Uniwersytecki Szpital Dziecięcy w Krakowie, Krakow, Poland
Instytut Centrum Zdrowia Matki Polki, Lodz, Poland
Instytut Pomnik - Centrum Zdrowia Dziecka, Warsaw, Poland
Hospital Universitari Vall d'Hebrón, Barcelona, Spain
Hospital Universitario 12 de Octubre, Madrid, Spain
Hospital Universitario La Paz, Madrid, Spain
Hospital Universitario Virgen del Rocío, Seville, Spain
Drottning Silvias Barn- och Ungdomssjukhus, Gothenburg, Sweden
Karolinska Universitetssjukhuset Huddinge, Stockholm, Sweden
University Hospitals Bristol and Weston NHS Foundation Trust, Bristol Royal Hospital for Children, Bristol, United Kingdom
NHS Greater Glasgow and Clyde, Royal Hospital for Children, Glasgow, United Kingdom
Alder Hey Children's NHS Foundation Trust, Liverpool, United Kingdom
Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Manchester University NHS Foundation Trust, Manchester, United Kingdom
Study leads
Radko Komers, MD, PhD
Study Director
Travere Therapeutics, Inc.